215160-96-6

215160-96-6 - Names and Identifiers

Name	3α,30-Diacetyloxy-12α-hydroxy-23-oxoeupha-7,24-dien-21,16β-olid-28-oic acid 28-O-β-D-glucopyranosyl ester
Synonyms	3Α,30-DIACETOXY-12Α-HYDROXY-23-OXOEUPHA-7,24-DIEN-21,16Β-OLID-28-OIC ACID 28-O-Β-D-GLUCOPYRANOSYL ES 3α,30-Diacetoxy-12α-hydroxy-23-oxoeupha-7,24-dien-21,16β-olid-28-oic acid 28-O-β-D-glucopyranosyl ester 3α,30-Diacetyloxy-12α-hydroxy-23-oxoeupha-7,24-dien-21,16β-olid-28-oic acid 28-O-β-D-glucopyranosyl ester Lanosta-7,24-diene-21,28-dioic acid, 3,30-bis(acetyloxy)-12,16-dihydroxy-23-oxo-, γ-lactone, 3-β-D-glucopyranosyl ester, (3α,4α,12α,13α,14β,16β,17α)- (9CI)
CAS	215160-96-6

215160-96-6 - Physico-chemical Properties

Molecular Formula	C40H56O15
Molar Mass	776.87
Density	1.38±0.1 g/cm3(Predicted)
Boling Point	871.0±65.0 °C(Predicted)
Appearance	Powder
pKa	12.51±0.70(Predicted)
Storage Condition	2-8℃

215160-96-6 - Introduction

3α, Ti, 24-dien-21,16β-olid-28-oic acid 28-O-β-D-glucopyranosyl ester is a compound whose chemical properties, uses, preparation methods and safety information are as follows:

Chemical Properties:
-chemical formula: C41H56O12
-Molecular weight: 752.87g/mol
-Appearance: White to light yellow solid substance

Use:
-Due to its natural source and biological activity, this compound is often used as an ingredient in traditional Chinese medicine or plant extracts.
-It may have anti-inflammatory, anti-tumor, antioxidant, antibacterial and other activities, so it may have potential research and application value in the field of medicine.

Method:
-Due to the special chemical structure of this compound, there are many different synthesis methods. A common preparation method is to use raw materials from natural plants, such as Gesneria, to extract and purify, and then modify specific chemical functional groups to form the target compound.

Safety Information:
-This compound has limited safety information and has not been extensively evaluated and studied for toxicity.
-When conducting any related activity research or using the compound, the agreed laboratory safety procedures should be followed.
-Adequate safety assessment and clinical research must be conducted before human use or further research applications.

Last Update：2024-04-09 21:04:16